AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $499,629 | +37.4% | 9,878 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $363,622 | +62.0% | 7,788 | +32.7% | 0.00% | +100.0% |
| Q1 2023 | $224,510 | -37.3% | 5,868 | -10.2% | 0.00% | -50.0% |
| Q4 2022 | $358,173 | +186.5% | 6,536 | +77.4% | 0.00% | +100.0% |
| Q3 2022 | $125,000 | +257.1% | 3,684 | 0.0% | 0.00% | – |
| Q2 2022 | $35,000 | -35.2% | 3,684 | -3.9% | 0.00% | – |
| Q1 2022 | $54,000 | +8.0% | 3,835 | +62.6% | 0.00% | – |
| Q4 2021 | $50,000 | -5.7% | 2,359 | 0.0% | 0.00% | – |
| Q3 2021 | $53,000 | -10.2% | 2,359 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | -13.2% | 2,359 | 0.0% | 0.00% | – |
| Q1 2021 | $68,000 | +11.5% | 2,359 | 0.0% | 0.00% | – |
| Q4 2020 | $61,000 | -16.4% | 2,359 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $73,000 | – | 2,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
| venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
| Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
| Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
| Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
| Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
| Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
| Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
| EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
| Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |